Evidence map›Paper›PMID 33527221›Full record

ArticleEJNMMI radiopharmacy and chemistry2021

Production, purification, and radiolabeling of the

Brooke L McNeil, Andrew K H Robertson, Winnie Fu, Hua Yang, Cornelia Hoehr, Caterina F Ramogida, Paul Schaffer

Open access · goldAbstract read
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Picolinamide-functionalized macrocyclic chelators forInorganic chemistry frontiers · 2026
    Article
  3. Article
  4. Emerging Theranostic Radiometals (Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  5. La-[Dalton transactions (Cambridge, England : 2003) · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Minimising the impact of stableEJNMMI radiopharmacy and chemistry · 2025
    Article
  16. EJNMMI radiopharmacy and chemistry · 2025
    Review
  17. Article
  18. Article
  19. Quantitative SPECT imaging ofEJNMMI physics · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Brooke L McNeil *Life Sciences Division, TRIUMF, Vancouver, BC, Canada.
Andrew K H Robertson *Life Sciences Division, TRIUMF, Vancouver, BC, Canada.
Winnie FuLife Sciences Division, TRIUMF, Vancouver, BC, Canada.
Hua YangLife Sciences Division, TRIUMF, Vancouver, BC, Canada.
Cornelia HoehrLife Sciences Division, TRIUMF, Vancouver, BC, Canada.
Caterina F RamogidaLife Sciences Division, TRIUMF, Vancouver, BC, Canada. cfr@sfu.ca.ORCID http://orcid.org/0000-0003-4815-2647
Paul SchafferLife Sciences Division, TRIUMF, Vancouver, BC, Canada. pschaffer@triumf.ca.
TRIUMF · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLead-212 (

resultsProton irradiation (12.8 MeV) of natural and enriched thallium-203 (

conclusionThe production of

Indexed as

ChelatorsCyclenDOTALead-203Lead-212PyridylRadiolabelingThallium-203TheranosticThorium-228 generator

Identifiers

PMID33527221
PMCPMC7851237
OpenAlexW3111997102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.